Fig. 1 · Structure
Documents & Downloads
RA-263
Radiosensitizer
RA-263 is a 2-nitroimidazole nucleoside that functions as a radiosensitizer. This compound enhances the efficacy of radiation therapy by increasing the sensitivity of tumor cells to ionizing radiation. RA-263 is primarily utilized in cancer research to investigate combined modality treatments and to explore mechanisms of radioresistance in various tumor models.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 82205-95-6 |
| Applications | Radiosensitizer |
| Formula | C9H11N3O5 |
| Molecular Weight | 241.20 |
| SMILES | OC1C(CO)OC(N2C=CN=C2[N+]([O-])=O)C=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.